Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Acta Paediatr ; 100(8): e75-9, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21352358

RESUMEN

AIM: To determine the relationship between blood tests and oesophageal histology in Eosinophilic oesophagitis (EoE). METHODS: All children diagnosed with EoE at one hospital from 2000 to 2009 were considered for inclusion in this study. Three blood test results were analysed, blood eosinophil count, serum total immunoglobulin E (IgE) and radioallergosorbent tests (RAST) to common food allergens. Oesophageal histology was prospectively re-reviewed, and mean eosinophil counts were enumerated. Blood test results were correlated with oesophageal eosinophil counts using Spearman's rank test. RESULTS: Forty children (70% boys) were included in this study, median age at diagnosis 6.5 years (range 0-15). At the time of diagnosis, 78% of children had a raised blood eosinophil count, 90% had a raised serum total IgE and 83% had one or more positive RAST tests. The mean oesophageal eosinophil count was significantly correlated with both blood eosinophil count (p=0.008) and serum total IgE level (p=0.008). CONCLUSION: This study shows that blood tests are often abnormal in children with EoE at the time of diagnosis. Our data demonstrate an association between histological abnormalities and blood test results in children with EoE.


Asunto(s)
Esofagitis Eosinofílica/diagnóstico , Adolescente , Niño , Preescolar , Esofagitis Eosinofílica/sangre , Esofagitis Eosinofílica/patología , Eosinófilos , Esófago/patología , Femenino , Hipersensibilidad a los Alimentos/diagnóstico , Humanos , Inmunoglobulina E/sangre , Lactante , Recuento de Leucocitos , Masculino , Prueba de Radioalergoadsorción
2.
J Pediatr Gastroenterol Nutr ; 50 Suppl 1: S14-34, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20081542

RESUMEN

OBJECTIVE: To systematically review the evidence base for the medical (pharmaceutical and nutritional) treatment of paediatric inflammatory bowel disease. METHODS: Key clinical questions were formulated regarding different treatment modalities used in the treatment of paediatric (not adult-onset) IBD, in particular the induction and maintenance of remission in Crohn disease and ulcerative colitis. Electronic searches were performed from January 1966 to December 2006, using the electronic search strategy of the Cochrane IBD group. Details of papers were entered on a dedicated database, reviewed in abstract form, and disseminated in full for appraisal. Clinical guidelines were appraised using the AGREE instrument and all other relevant papers were appraised using Scottish Intercollegiate Guidelines Network methodology, with evidence levels given to all papers. RESULTS: A total of 6285 papers were identified, of which 1255 involved children; these were entered on the database. After critical appraisal, only 103 publications met our criteria as evidence on medical treatment of paediatric IBD. We identified 3 clinical guidelines, 1 systematic review, and 16 randomised controlled trials; all were of variable quality, with none getting the highest methodological scores. CONCLUSIONS: This is the first comprehensive review of the evidence base for the treatment of paediatric IBD, highlighting the paucity of trials of high methodological quality. As a result, the development of clinical guidelines for managing children and young people with IBD must be consensus based, informed by the best-available evidence from the paediatric literature and high-quality data from the adult IBD literature, together with the clinical expertise and multidisciplinary experience of paediatric IBD experts.


Asunto(s)
Corticoesteroides/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéutico , Factores Inmunológicos/uso terapéutico , Enfermedades Inflamatorias del Intestino/tratamiento farmacológico , Adolescente , Corticoesteroides/efectos adversos , Antiinflamatorios no Esteroideos/efectos adversos , Huesos/efectos de los fármacos , Niño , Humanos , Factores Inmunológicos/efectos adversos , Enfermedades Inflamatorias del Intestino/dietoterapia , Quimioterapia de Mantención , Mesalamina/uso terapéutico , Inducción de Remisión , Sulfasalazina/uso terapéutico
3.
Acta Paediatr ; 99(3): 418-21, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19930192

RESUMEN

AIM: To assess self-reported Quality of life (QoL) in children with Gastro-oesophageal reflux disease (GORD) aged 5-18 and compare this with both disease and healthy control children in a prospective consecutive sample. METHODS: All children attending a tertiary paediatric gastroenterology clinic from February 2009 to May 2009 with GORD, chronic constipation and inflammatory bowel disease (IBD) were asked to complete the validated PedsQL generic QoL assessment (self-report) at their clinic appointment. The PedsQL considers physical, emotional, social and school domains and is scored from 0 to 100. Healthy children were also recruited from the same site. Groups were compared using the independent samples Student's t-test. RESULTS: A total of 184 children completed the assessment [103 (56%) male, mean age 10.7 years +/- 3.3] including 40 children with GORD, 44 with chronic constipation, 59 with IBD and 41 healthy children. QoL was significantly lower in the GORD group compared with both children with IBD (74 vs. 82) and healthy children (74 vs. 84), and was comparable to that of children with chronic constipation (74 vs. 74). CONCLUSIONS: Self-reported QoL in children with GORD attending a tertiary paediatric gastroenterology clinic is significantly reduced compared with both healthy children and children with IBD.


Asunto(s)
Reflujo Gastroesofágico , Calidad de Vida , Adolescente , Estudios de Casos y Controles , Niño , Preescolar , Enfermedad Crónica , Estreñimiento , Femenino , Reflujo Gastroesofágico/fisiopatología , Reflujo Gastroesofágico/psicología , Humanos , Enfermedades Inflamatorias del Intestino , Masculino , Estudios Prospectivos , Encuestas y Cuestionarios
4.
Early Hum Dev ; 81(1): 117-22, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15707723

RESUMEN

The occurrence in the neonatal period and into early infancy of two inflammatory conditions, necrotising enterocolitis (NEC), and allergic colitis, that do not occur in later life highlight the peculiar vulnerability of the gastrointestinal tract in the newborn period to otherwise innocuous insults. The pathogenesis of the relatively benign allergic colitis as a mucosal inflammatory process driven by dietary antigens is relatively well characterised, and its treatment with dietary manipulation is well established. For NEC, hypoxic/ischaemic insult, mucosal immaturity, and its interaction with the intestinal microflora are understood to be the main factors in pathogenesis. Thus far, the most productive interventions have been in preventative approaches, in particular feeding strategies, to reduce the incidence of the condition whilst establishing adequate growth and progression onto enteral feeding. For established NEC, supportive medical therapy or surgical intervention remains the mainstay or treatment, although novel therapies, such as platelet-activating factor (PAF) inhibitors and epidermal growth factor (EGF), have shown some promise in animal models of the condition.


Asunto(s)
Colitis/fisiopatología , Colitis/terapia , Enterocolitis Necrotizante/fisiopatología , Enterocolitis Necrotizante/terapia , Tracto Gastrointestinal/patología , Enterocolitis Necrotizante/epidemiología , Enterocolitis Necrotizante/prevención & control , Factor de Crecimiento Epidérmico , Humanos , Recién Nacido , Factor de Activación Plaquetaria/antagonistas & inhibidores
5.
Aliment Pharmacol Ther ; 42(2): 142-57, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-26043941

RESUMEN

BACKGROUND: Paediatric inflammatory bowel disease (IBD) is associated with weight loss, growth restriction and malnutrition. Bone mass deficits are well described, little is known about other body composition compartments. AIMS: To define the alterations in non-bone tissue compartments in children with IBD, and explore the effects of demographic and disease parameters. METHODS: A systematic search was carried out in the PubMed (www.ncbi.nlm.nih.gov/pubmed) and Web of Science databases in May 2014 (limitations age <17 years, and composition measurements compared with a defined control population). RESULTS: Twenty-one studies were included in this systematic review, reporting on a total of 1479 children with IBD [1123 Crohn's disease, 243 ulcerative colitis], pooled mean age 13.1 ± 3.2 years, and 34.9% female. Data were highly heterogeneous, in terms of methodology and patients. Deficits in protein-related compartments were reported. Lean mass deficits were documented in 93.6% of Crohn's disease and 47.7% of ulcerative colitis patients when compared with healthy control populations. Lower lean mass was common to both sexes in Crohn's disease and ulcerative colitis, deficits in females with persisted for longer. Fat-related compartment findings were inconsistent, some studies report reductions in body fat in new diagnosis/active Crohn's disease. CONCLUSIONS: It is clear that almost all children with Crohn's disease and half with ulcerative colitis have reduced lean mass, however, body fat alterations are not well defined. To understand what impact this may have on health and disease in children with IBD, further studies are needed to identify in which tissues these deficits lie, and to quantify body fat and its distribution.


Asunto(s)
Composición Corporal , Enfermedades Inflamatorias del Intestino/complicaciones , Adolescente , Pesos y Medidas Corporales , Densidad Ósea , Niño , Preescolar , Colitis Ulcerosa/complicaciones , Enfermedad de Crohn/complicaciones , Femenino , Humanos , Masculino
6.
Arch Dis Child ; 98(9): 702-6, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23814082

RESUMEN

Eosinophilic oesophagitis (EO) is a chronic immune/antigen-mediated oesophageal disease, with the immune reaction most likely directed to foods but on occasion also to aeroallergens. Clinically, it is characterised by symptoms of oesophageal dysfunction in subjects who typically have other indicators of an atopic tendency. Older children (and adults) frequently present with dysphagia and can have strictures (which may require dilatation). The diagnosis is dependent on an eosinophil-predominant oesophageal inflammation, with 15 or more eosinophils per high-powered field, now generally accepted as a necessary cut-off level of infiltration, which together with other clinical data (eg, oesophageal pH/impedance studies) can help discriminate EO from other potential causes of symptoms such as gastro-oesophageal reflux disease. Recommended therapies, which may need to be long term, are dietary antigen exclusion (with elemental feeds or an exclusion diet) and/or topical corticosteroids.


Asunto(s)
Corticoesteroides/uso terapéutico , Dilatación/métodos , Esofagitis Eosinofílica/diagnóstico , Eosinófilos/inmunología , Esófago/patología , Inhibidores de la Bomba de Protones/uso terapéutico , Corticoesteroides/efectos adversos , Diagnóstico Diferencial , Dilatación/efectos adversos , Esofagitis Eosinofílica/tratamiento farmacológico , Esofagitis Eosinofílica/terapia , Eosinófilos/patología , Esófago/inmunología , Humanos , Inhibidores de la Bomba de Protones/efectos adversos , Resultado del Tratamiento
7.
Arch Dis Child ; 97(1): 78-83, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21505142

RESUMEN

Up to 25% of patients with Crohn's disease and ulcerative colitis present before the age of 18 years. Although the pathophysiology of inflammatory bowel disease presenting in childhood does not differ fundamentally from that presenting in adulthood, managing these younger patients requires special consideration in light of growth and the potential long term consequences of both the disease and its treatments. Therapeutic approaches have changed in recent years, and there is a fuller appreciation of the role (and risks) of anti-tumour necrosis factor monoclonal therapy.


Asunto(s)
Enfermedades Inflamatorias del Intestino/terapia , Adolescente , Niño , Preescolar , Femenino , Glucocorticoides/uso terapéutico , Trastornos del Crecimiento/etiología , Humanos , Inmunosupresores/uso terapéutico , Lactante , Enfermedades Inflamatorias del Intestino/complicaciones , Enfermedades Inflamatorias del Intestino/diagnóstico , Imagen por Resonancia Magnética , Masculino , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores
8.
Arch Dis Child ; 96(2): 192-4, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20515971

RESUMEN

AIM: To determine the incidence and examine the epidemiology of achalasia before the age of 16 years in the UK from 1998 to 2008. METHODS: 25 regional paediatric surgery referral centres were asked to provide demographic and epidemiological data on cases of childhood achalasia from 1998 to 2008. Incidence rates were calculated from national population estimates. The data collection method was validated in one centre. RESULTS: 228 patients from 24 centres were diagnosed with achalasia before 16 years in the UK from 1998 to 2008. The mean incidence from 1998 to 2008 was 0.18/10(5) children/year. Where additional data was provided (69-81% of cases) 56% of children were male and the mean age of diagnosis was 10.9 years. Logistic regression analysis showed a rising incidence, with an OR of 1.12 (95% CI 1.06 to 1.16) for having achalasia in each successive year. The validation of this methodology showed that 95% of true cases and no false cases were identified. CONCLUSIONS: The mean incidence of childhood achalasia in the UK from 1998 to 2008 is at least 0.18/10(5) children/year; this has risen over the last 11 years and compared to the only other study published in 1988.


Asunto(s)
Acalasia del Esófago/epidemiología , Adolescente , Distribución por Edad , Niño , Preescolar , Bases de Datos como Asunto , Femenino , Humanos , Incidencia , Lactante , Recién Nacido , Masculino , Reino Unido/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA